Source link : https://www.newshealth.biz/health-news/lymphedema-risk-no-higher-with-3-week-rt-regimen-in-early-breast-cancer/
A shorter radiotherapy (RT) course proved its mettle in early-stage breast cancer in terms of lymphedema risk, without negatively impacting survival outcomes, according to a phase III trial from France. In the HypoG-01 study, a 3-week course of moderately hypofractionated locoregional RT was noninferior to 5 weeks of normofractionated RT for the primary endpoint of […]
Author : News Health
Publish date : 2024-09-17 21:38:26
Copyright for syndicated content belongs to the linked Source.